Overview
Adam Goldrich is a Hematologist Oncology specialist and a Hematologist in Laurel, Maryland. Dr. Goldrich is rated as an Experienced provider by MediFind in the treatment of Liposarcoma. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Multiple Myeloma. Dr. Goldrich is currently accepting new patients.
His clinical research consists of participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
7350 Van Dusen Rd, Suite 370, Laurel, MD 20707
7704 Matapeake Business Dr, Suite 200, Brandywine, MD 20613
10710 Charter Dr, Suite G020, Columbia, MD 21044
11886 Healing Way, Silver Spring, MD 20904
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
12 Clinical Trials
Skip Viragh Outpatient Cancer Center
Dr. Meyer will serve as the lead medical oncologist for adult sarcoma patients, and will focus on building the Adult Sarcoma and Connective Tissue Oncology Program. In collaboration with pediatric oncologist David Loeb, M.D., Ph.D., and orthopaedic surgeon Kristy Weber, M.D., Meyer will bring novel therapies to the clinic for sarcoma patients. Meyer received his bachelors and masters degrees in cell and molecular biology from Stanford University. From there, he joined the Medical Scientist Training Program at Baylor College of Medicine and earned his medical degree followed by a doctorate in immunology. Meyer completed his residency at the University of Maryland and served as chief resident in medicine from 2004-2005. Afterward, he joined our fellowship program in medical oncology and has been working in the laboratory of Jonathan Powell, M.D., Ph.D., on projects relating to the characterization of molecular regulatory pathways involved in T-cell activation and energy. As a third-year fellow, Meyer served as the chief fellow for our Training Programs in Hematology and Medical Oncology and he received a Young Investigator Award from the American Society of Clinical Oncology in 2010. Dr. Meyer is rated as a Distinguished provider by MediFind in the treatment of Liposarcoma. His top areas of expertise are Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Bone Tumor, and Ganglioneuroblastoma.
Dennis Priebat is a Hematologist Oncology specialist and an Oncologist in Washington, Washington, D.c.. Dr. Priebat is rated as a Distinguished provider by MediFind in the treatment of Liposarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, and Rhabdomyosarcoma Embryonal.
Virginia Cancer Specialists, P.C.
Alexander Spira is a Hematologist and an Oncologist in Leesburg, Virginia. Dr. Spira is rated as an Elite provider by MediFind in the treatment of Liposarcoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, EGFR Positive Lung Cancer, and Tissue Biopsy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Goldrich isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Goldrich isDistinguished. Learn about Breast Cancer.
- Paget Disease of the BreastDr. Goldrich isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Adult Soft Tissue SarcomaDr. Goldrich isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- AnemiaDr. Goldrich isAdvanced. Learn about Anemia.
- Childhood Iron Deficiency AnemiaDr. Goldrich isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Chromophobe Renal Cell CarcinomaDr. Goldrich isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Goldrich isAdvanced. Learn about Clear Cell Sarcoma.
- Colorectal CancerDr. Goldrich isAdvanced. Learn about Colorectal Cancer.
- Experienced
- Acute Monoblastic Leukemia (AmoL)Dr. Goldrich isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Mountain SicknessDr. Goldrich isExperienced. Learn about Acute Mountain Sickness.
- Adrenal CancerDr. Goldrich isExperienced. Learn about Adrenal Cancer.
- Adult Immune ThrombocytopeniaDr. Goldrich isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Goldrich isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Goldrich isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.